Subglottic haemangioma: Controversies in management

Area of Science:

• Pediatric Otolaryngology
• Laser Surgery
• Pharmacotherapy

Background:

• Subglottic haemangioma (SGH) is a rare, benign vascular tumor that can cause life-threatening airway obstruction in infants.
• Timely and effective management is crucial to prevent complications such as respiratory distress and failure to thrive.

Purpose of the Study:

• To present a stepped-care approach for managing subglottic haemangioma (SGH).
• To evaluate the efficacy of different treatment modalities for SGH in pediatric patients.

Main Methods:

• Case report detailing the management of two pediatric patients with SGH.
• Utilized CO2 laser vaporization as a primary treatment in one case.
• Employed a sequential approach of laser therapy followed by interferon 2-alpha in the second case.

Main Results:

• Both treatment strategies successfully controlled SGH in the reported cases.
• Neither patient required a tracheostomy, indicating successful airway management.
• CO2 laser vaporization and interferon therapy demonstrated significant therapeutic benefit.

Conclusions:

• A stepped-care approach involving laser surgery and/or interferon is effective for SGH.
• Interdisciplinary cooperation and vigilant patient surveillance are key to optimal outcomes.
• Non-invasive treatment options can obviate the need for tracheostomy in SGH management.